12:00 AM
Oct 08, 2012
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Cell Therapeutics completes private placement of convertible preferred stock

Cell Therapeutics Inc. (NASDAQ:CTIC; Milan:CTIC), Seattle, Wash.
Business: Cancer, Hematology
Date completed: 10/5/12

Read the full 48 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >